Erratum (DOI:10.1016/j.transproceed.2007.05.065);Fenoldopam vs Dopamine as a Nephroprotective Strategy During Living Donor Kidney Transplantation: Preliminary Data

Transplantation Proceedings

Volumn 39, Issue 6, 2007, Pages 1794-1796

  Sorbello, M ^a   Morello, G ^a   Paratore, A ^a   Cutuli, M ^a   Mistretta, G ^a   Belluoccio, A A ^a,b   Veroux, M ^a   Veroux, P ^a   Macarone, M ^a   Gagliano, M ^a   Mangianeli, S ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; CHLORIDE; CISATRACURIUM; DOBUTAMINE; DOPAMINE; ESMOLOL; FENOLDOPAM; FENTANYL; POTASSIUM; PROPOFOL; SEVOFLURANE; SODIUM;

ADULT; ANESTHESIA; ANTHROPOMETRIC PARAMETERS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; HUMAN; HYPOTENSION; INFUSION; KIDNEY TRANSPLANTATION; LIVING DONOR; PRIORITY JOURNAL; RENAL PROTECTION; STATISTICAL SIGNIFICANCE; TACHYCARDIA; URINARY EXCRETION; URINE VOLUME;

EID: 34547561869     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.10.006     Document Type: Erratum

References (7)

1. Kellum J.A., and Decker J.M. Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 29 (1526) 2001
2. Lassnigg A., Donner E., Grubhofer G., et al. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 11 (2000) 97
3. Drager L.F., Andrade L., Barros De Toledo J.F., et al. Renal effects of N-acetylcisteine in patients at risk for contrast nephropathy: decrease in oxidant stress mediated renal tubular injury. Nephrol Dial Transpl 19 (2004) 1803
4. Halpenny M., Markos F., Snow H.M., et al. Effects of prophylactic fenoldopam infusion on renal blood flow and renal tubular function during acute hypovolemia in anesthetized dogs. Crit Care Med 29 (2001) 855
5. Tumlin J.A., Wang A., Murray P.T., et al. Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: A pilot trial in the prevention of contrast nephropathy. Am Heart J 143 (2002) 894
6. Brienza N., Malcangi V., Dalfino L., et al. A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients. Crit Care Med 34 (2006) 707
7. Mathur V.S., Swan S.K., Lambrecht L.J., et al. The effects of Fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects. Crit Care Med 27 (1832) 1999